|
|
|
|
Vol. 57, Issue 2, 317-323, February 2000
Departments of Medicine and Molecular Pharmacology and the Albert Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, Bronx, New York.
| |
Abstract |
|---|
|
|
|---|
In previous reports, an E45K mutation in reduced folate carrier (RFC1) resulted in marked substrate-specific changes in folate binding and the induction of an obligatory inorganic anion requirement for carrier function. In this study, site-directed mutagenesis was employed to further characterize the role of glutamate-45 in carrier function by replacement with glutamine, arginine, aspartate, leucine, or tryptophan followed by tranfection of the mutated cDNAs into the MTXrA line, which lacks a functional endogenous carrier. Alterations in transport function with amino acid substitutions at this residue were not charge related. Hence, E45Q, E45R, and E45K all 1) increased carrier affinity for 5-formyltetrahydrofolate ~4-fold, 2) increased affinity for folic acid ~6- to 10-fold, 3) did not change affinity for 5-methyltetrahydrofolate, and 4) except for E45R decreased affinity for methotrexate (2- to 3-fold). In contrast, mutations E45D, E45L, and E45W generally reduced affinity for all these folates except for folic acid. Finally, chloride-dependent influx was only noted in the E45R mutant. These data further substantiate the important role that glutamate-45 plays in the selectivity of binding of folates to RFC1 and establish that it is the addition of a positive charge at this site and not the loss of a negative charge that results in the induced anion dependence. These and other studies indicate that mutations in the first transmembrane domain can have a markedly selective impact on the affinity of RFC1 for folate compounds and in particularly a highly salutary effect on binding of the oxidized folate, folic acid.
| |
Introduction |
|---|
|
|
|---|
The
reduced folate carrier (RFC1), a member of the major facilitator
superfamily of transport carriers, delivers folates into cells that are
essential for one-carbon-requiring biosynthetic reactions (Pao et al.,
1998
). The RFC1 gene from various species was recently cloned (Dixon et
al., 1994
; Williams et al., 1994
; Moscow et al., 1995
; Prasad et al.,
1995
; Williams and Flintoff, 1995
; Wong et al., 1995
) and its murine
and human genomic organizations characterized (Brigle et al., 1997
;
Tolner et al., 1997
, 1998
). Information is now evolving on RFC1
domains, in general, and specific amino acids, in particular, that
plays key roles in function and substrate specificity. This has been
based largely, to this point, on the characterization of mutant
carriers that have been identified under antifolate selective pressure.
The first transmembrane domain has been identified as one important
site for mutation under these conditions (Jansen et al., 1998
; Tse et
al., 1998
; Zhao et al., 1998a
, 1998b
).
In an initial report from this laboratory, the substitution of lysine
for glutamate at amino acid 45 in murine RFC1 resulted in a transport
phenotype that displayed several interesting features (Zhao et al.,
1998b
). The influx Ki for methotrexate
(MTX) was increased and the Ki for folic
acid and 5-formyltetrahydrofolate (5-CHO-THF) was decreased (Zhao et
al., 1998b
). Wild-type RFC1 in L1210 cells is competitively inhibited
by a variety of inorganic and organic anions (Goldman, 1971
; Henderson
and Zevely, 1983
). However, the E45K mutation resulted in the induction
of an obligatory requirement for small inorganic anions for carrier
function as indicated by an anion-dependent augmentation of influx
Vmax. Recently, this same mutation in RFC1
was also identified in a MTX-resistant human leukemia cell line
(CCRF-CEM/MTX) in which there was a similar change in the spectrum of
affinities for different folate substrates as well as the induction of
chloride-dependent MTX influx (Jansen et al., 1998
).
In this paper, we describe the application of site-directed mutagenesis to further characterize the role that the glutamate-45 residue plays in the selectivity of binding of folate compounds and establish that the anion requirement observed for function of the lysine-substituted mutated carrier is due to the addition of the positive charge at this site rather than the loss of the negatively charged glutamate residue.
| |
Materials and Methods |
|---|
|
|
|---|
Chemicals. [3',5',7-3H](6S)-5-CHO-THF and [3', 5',7-3H](6S)-5-methyltetrahydrofolate (5-CH3THF), obtained from Moravek Biochemicals (Brea, CA), and [3',5',7-3H]MTX, obtained from Amersham (Arlington Heights, IL), were purified by HPLC. Unlabeled MTX and 5-CHO-THF, provided by Lederle (Carolina, Puerto Rico), as well as folic acid and 5-CH3-THF, obtained from Sigma (St. Louis, MO), were also purified by HPLC. Silicon and mineral oil used for the specific surface binding assay were purchased from Aldrich Chemical (Milwaukee, WI). All other reagents were of the highest purity available from commercial sources.
Cell Culture Conditions.
L1210 leukemia cells and the
MTXrA line, which lacks endogenous RFC1 function
(Schuetz et al., 1989
; Brigle et al., 1995
), were grown in RPMI 1640 medium containing 2.3 µM folic acid, supplemented with 5% bovine
calf serum (HyClone, Logan, UT), 2 mM glutamine, 20 µM
2-mercaptoethanol, penicillin (100 U/ml), and streptomycin (100 µg/ml) at 37°C in a humidified atmosphere of 5%
CO2.
Site-Directed Mutagenesis of RFC1.
Site-directed mutagenesis
was carried out according to the QuickChange protocol from Strategene
(La Jolla, CA). Wild-type RFC1 cDNA was isolated from L1210 cells and
directionally cloned into the mammalian expression vector pcDNA3.1(+)
(Invitrogen, San Diego, CA) in the same way as reported for the mutated
RFC1-E45K (Zhao et al., 1998b
). The resulting vector was used as the
template, and two completely complementary 24-mer oligonucleotides,
which carry the targeted nucleotide changes in the middle region, were used as the primers for the QuickChange protocol. Sense primers containing the degenerate codons for amino acid 45 are listed in Table
1. The codons for the amino acids
introduced were chosen so that the single HindIII
restriction site in the RFC1 coding region was eliminated to facilitate
screening for positive clones. The RFC1 expression vector (30 ng), a
pair of primers (each 150 ng), dNTP (each 10 ng), and Pfu
polymerase (2.5 U) were dissolved in 50 µl of reaction buffer. The
temperature was cycled 17 times for 30 s at 95°C, 1 min at
55°C, and 14 min at 68°C. DpnI (10 U) was added and
incubated at 37°C for 1 h to digest the parental supercoiled
dsDNA. The mixture (1 µl) was transformed into 50 µl DH5
competent cells (Life Technologies, Rockville, MD). Plasmids harboring
the mutations were identified by restriction analysis with
HindIII and then confirmed by DNA automated sequencing, in the Albert Einstein Comprehensive Cancer Center DNA Sequencing Facility, to be free of any mutations in the RFC1 coding region that
might be introduced by Pfu polymerase. The plasmids were then ready for transfection.
|
Transfections. MTXrA (1 × 107 cells) were electroporated (250 V, 200 µf) with 50 µg of nonlinearized pcDNA3.1(+) harboring the mutated RFC1 cDNA in a final volume of 800 µl of serum-free RPMI 1640 medium. Cells were then diluted in 20 ml of complete RPMI 1640 medium, allowed to recover for 48 h, adjusted to 2 × 105 cells/ml in medium containing G418 (750 µg/ml of active drug), and then distributed into 96-well plates at ~4 × 104 cells/well. About 20 surviving clones were picked for each transfection and expanded in the presence of G418. After initial screening for MTX growth inhibition, one clone with the lowest MTX IC50 was chosen for each mutation and subjected to further study. The transfectants were maintained in RPMI 1640 medium containing 750 µg/ml of G418.
Northern Analyses.
Total RNA was isolated from the
transfectants, MTXrA, and L1210 cells using the
TRIzol reagent (Life Technologies). RNA (20 µg) was resolved by
electrophoresis on 1% agarose gels containing formaldehyde. Transfers
and hybridizations were performed as described previously (Zhao et al.,
1997
). Transcripts were quantitated by PhosphorImager analysis of the
hybridization signals and normalized to
-actin.
Analysis of Specific 5-CH3-THF Binding to the Cell Surface as a Measure of RFC1 Membrane Expression. Cells were harvested, washed twice with, and resuspended in, HEPES (190 mM HEPES, 5 mM KCl, 2 mM MgCl2, 5 mM glucose, pH 7.4) to a density of 5 × 107 cells/ml. Portions of 200 µl were incubated with 1 µM [3H]5-CH3-THF (specific activity of 800 dpm/pmol) at 0°C for 10 min in the presence or absence of a 10-fold excess of unlabeled 5-CH3-THF. Bound and free ligands were then separated by centrifugation of a 180-µl aliquot through 150 µl of a mixture of silicon and mineral oil (9:1) in a 5.8 × 47.5-mm plastic (0.4 ml) microfuge tube at 14,000 rpm for 15 s. The tip of the tube, which contained the cell pellet, was cut off, dropped into a glass scintillation vial, and the contents digested with 0.5 ml 1 N KOH following which scintillation fluid was added and radioactivity determined. Other tared tubes, containing pellets with an equal number of cells, were weighed after drying to determine dry weight so that surface binding could be expressed as nmol/g dry wt. of cells.
For 5-CH3-THF binding kinetics, six substrate concentrations, 0.05, 0.1, 0.2, 0.5, 0.75, and 1.0 µM, were used in the absence and presence of 10 µM unlabeled 5-CH3-THF. Under these conditions, the binding constant (Kb) for 5-CH3-THF in MTXrA-R16 cells, which overexpress wild-type RFC1 (Brigle et al., 1995Transport Studies.
Influx measurements for all the folate
compounds were performed by methods described in detail previously in
HEPES-buffered saline (HBS) (20mM HEPES, 140 mM NaCl, 5 mM KCl,
2 mM MgCl2, 5 mM glucose, pH 7.4) or HEPES buffer (190 mM
HEPES, 5 mM KCl, 2 mM MgCl2, 5 mM glucose, pH 7.4) (Zhao et
al., 1997
). K+-HEPES-sucrose buffer (20 mM HEPES, 235 mM
sucrose, pH 7.4) and Mg2+-free HBS buffer (20 mM HEPES, 140 mM NaCl, 5 mM glucose, pH 7.4) were also used in some experiments.
Before transport studies with the transfectants, cells were expanded
for only three to seven doublings without further addition of G418 to
ensure that expression of the mutated RFC1 was maintained.
| |
Results |
|---|
|
|
|---|
Expression of E45 Site-Directed Mutants in MTXrA
Cells.
The cDNAs of the mutated RFC1s were transfected into the
murine L1210 leukemia cell line, MTXrA, which
lacks endogenous RFC1 function due to a proline for alanine substitution at amino acid 130 within the fourth transmembrane domain
(Schuetz et al., 1989
; Brigle et al., 1995
). One transfected clone,
with the greatest restoration of sensitivity to MTX for each mutant,
was identified and used for further detailed studies. The nomenclature
for these cell lines is MTXrA followed by the
specific amino acid substitution. Figure
1 shows a representative Northern blot
analysis. The radioactive blots were quantitated directly by
PhorphorImage analysis, and RFC1 mRNA levels were normalized to
-actin and a wild-type L1210 cell level of 1. The amount of RFC1
transcript in the transfectants derived from the expression vector was
higher than that of L1210 cells by factors of 2.6 to 8.0. Consistent
with previous determinations, RFC1 mRNA in recipient
MTXrA cells was about half that of L1210 cells
(Brigle et al., 1995
; Zhao et al., 1998a
, 1998b
).
|
|
Folate Influx in Transfectants. Table 2 summarizes initial uptake rates for MTX, 5-CH3-THF, and 5-CHO-THF in all cell lines studied. The most active of the mutated carriers was E45Q. In fact, transport of 5-CHO-THF and 5-CH3-THF in MTXrA-E45Q cells was nearly three times faster than that in L1210 cells and far exceeded the rate of MTX transport. For the E45L carrier, influx of the reduced folates was comparable with that mediated by wild-type RFC1; MTX influx was ~50% less. RFC1 expression in both E45Q and E45L transfectants was comparable with the wild-type level in L1210 cells. For other mutated carriers, influx was decreased and residual activity of each of the folate substrates among the mutants varied considerably. The lowest activities were observed for the asparate and tryptophan substitutions. Although the membrane binding assay underestimates the level of E45W expression due to its high influx Ki (see Table 3 below), residual transport activity measured was <10% that mediated by wild-type RFC1
|
|
The Inhibitory Effect of 5-CHO-THF, 5-CH3-THF and Folic
Acid on MTX Influx Mediated by the Mutated Carriers.
Inhibition of
MTX influx by reduced folates and folic acid was assessed as a prelude
to the determination of the affinity of the mutated carriers for these
substrates. Three different concentrations of each inhibitor were used:
the wild-type influx Kt, one-fifth the
influx Kt, and five times the influx
Kt, along with a control in which no
inhibitor was added. As shown in the upper panel of Fig.
3, the potency of inhibition of MTX
influx by 5-CHO-THF was markedly altered in the transfectants as
compared with L1210 cells. Inhibition of MTX influx was 1) not
abolished even at a 5-CHO-THF concentration of 25 µM in
MTXrA-E45W cells, 2) markedly decreased in
MTXrA-E45D cells, 3) markedly increased in
MTXrA-E45Q and MTXrA-E45R
cells whereas 4) unchanged in MTXrA-E45L cells.
The pattern of inhibition of MTX influx by
5-CH3-THF resembled that of 5-CHO-THF, but
5-CH3THF inhibition appeared greater in
MTXrA-E45W and weaker in
MTXrA-E45R relative to L1210 cells (middle panel
of Fig. 3). Folic acid inhibition of MTX influx in the transfectants
differed from that observed with either 5-CHO-THF or
5-CH3-THF (lower panel). At all concentrations,
inhibition was markedly increased in MTXrA-E45Q,
MTXrA-E45R, and MTXrA-E45L
cells as compared with that of L1210 cells, whereas it was roughly
comparable in MTXrA-E45D and
MTXrA-E45W cells. These data were then used to
identify appropriate concentrations for determination of inhibitory
constants for these folates as indicated below.
|
Influx Kinetics. As indicated in Table 3, the influx Kt for MTX was increased in all mutated carriers except E45R; the greatest increase in Kt was observed with E45D. Influx kinetics could not be determined for E45W due to the very low level of transport activity. The influx Vmax was increased by a factor of 2 in E45Q, but influx was minimally decreased (Table 2), attributed to the accompanying 2-fold increase in influx Kt. The Vmax was unchanged in E45L and was decreased by 50-60% in the E45R and E45D transfectants as compared with that of L1210 cells; the latter can be explained, at least in part, by a comparable decrease in carrier protein expression (Fig. 2, Table 2).
Influx Ki for the other folates were then assessed by Dixon analysis and compared with wild-type RFC1 (Table 3). The influx Ki for 5-CH3-THF in E45K was also determined, and together with Kt for 5-CHO-THF influx and Ki for folic acid, which were reported previously (Zhao et al., 1998bThe Anion Dependence of MTX Influx in E45 Mutants.
Folate
transport in L1210 cells is inhibited by virtually all inorganic and
organic anions and influx is stimulated by the removal of chloride
(Goldman, 1971
; Henderson and Zevely, 1988
). In contrast, activity of
the E45K mutant was markedly reduced in the absence of chloride (Zhao
et al., 1998b
). To determine the effect of the other amino acid
substitutions on the anion-dependence of transport, all but 9 mM
extracellular chloride was replaced by HEPES and MTX influx was
assessed. MTX influx in HEPES buffer was increased ~150% in L1210
cells and all other transfectants except for E45Q in which the increase
was ~50% and E45R in which the effect was reversed with a 60%
decrease in influx (Fig. 4). The latter
was qualitatively the same as observed for E45K, and the increase in
MTX influx in MTXrA-E45R as extracellular
chloride was increased, similar to what was observed for 5-CHO-THF
influx in MTXrA-E45K cells (Fig.
5) (Zhao et al., 1998b
).
|
|
| |
Discussion |
|---|
|
|
|---|
Previous studies from this and other laboratories have begun to
elucidate some of the structure-function properties of the reduced
folate carrier. These insights have derived largely from analyses of
the functional consequences of mutations in RFC1 in cell lines obtained
under antifolate selective pressure augmented by chemical mutagenesis
(Zhao et al., 1999
). The first transmembrane domain has been identified
as one important site for mutations that result in antifolate drug
resistance with highly selective changes in the spectrum of carrier
affinities for folate substrates and/or mobilities of the
carrier-substrate complex (Tse et al., 1998
; Zhao et al., 1998a
,
1998b
). The current study was undertaken to further clarify the
structural basis for the functional changes that occurred when lysine
was substituted for glutamate at amino acid 45
increased affinity for
folic acid and 5-CHO-THF, decreased affinity for MTX, and the induction
of an obligatory requirement for small inorganic anions to allow
carrier function (Zhao et al., 1998b
).
Based on the substitution of glutamate with amino acids of different
charge, polarity, and size, the data indicate that preservation of the
negative charge at amino acid 45 is not an essential element in RFC1
function. In fact, replacement of glutamate with the uncharged glutamine, or positive-charged arginine, resulted in increased affinity
for 5-CHO-THF, a similar or greater affinity for
5-CH3-THF, and a markedly increased affinity for
folic acid as compared with wild-type carrier, as was observed also for
the lysine-substituted RFC1 (Zhao et al., 1998b
). It is of interest
that the loss of the negative charge has the most profound salutary
effect on folic acid binding with up to a 10-fold decrease in influx
Kt. Indeed, the only substituted amino acid
that produced a carrier with a slightly lower affinity for folic acid
than wild-type RFC1 was aspartate, and increased binding occurred even
with the tryptophan substitution despite its bulk. Another bulky
substitution of phenylalanine for isoleucine at amino acid residue 48 without a change in polarity produced an even greater increase in
affinity for folic acid with a 20-fold decline in influx
Kt (Tse et al., 1998
; Tse and Moran, 1998
).
Hence, it would appear that this region in the first transmembrane domain plays an important role in determining the very low affinity of
wild-type carrier for this oxidized folate.
Carrier functional activity is determined by affinity for the
substrate, carrier mobility, and the level of carrier protein expressed. Carrier protein levels at the cell surface were assessed using a specific binding assay for 5-CH3-THF. All
of the mutated carriers were expressed and processed to the cell
membrane and the measured levels were within a factor of ~2 of the
wild-type carrier. In the absence of murine RFC1 antibody, the efficacy of processing and extent to which carrier might be sequestered along
trafficking route cannot be assessed. In general, the level of mutated
protein present at the cell membrane (Fig. 2) was far lower than
expected based on a comparison of RFC1 mRNA (Fig. 1) in the
transfectants relative to L1210 cells. Discrepancies were also observed
for human RFC1 transfectants in which the amount of RFC1 mRNA or
protein far exceeded relative levels of RFC1 activity (Wong et al.,
1997
, 1998
). However, these studies go beyond protein identification to
the assessment of specific folate binding to RFC1 at the cell surface.
Based on the level of protein detected and the measured influx
Vmax for MTX, there were some
substrate-dependent differences in the mobility of the
carrier-substrate complexes, less or greater than wild-type RFC1, that
accompanied changes in influx Kt. This is
in contrast to the functional changes associated with the S
N mutation, at the adjacent amino acid 46, in which there was a highly
selective decline in carrier mobility that allowed a much greater rate
of translocation of carrier loaded with reduced folates than with MTX
without any change in the spectrum of affinities for these substrates
(Zhao et al., 1998a
).
The further demonstration that only arginine, of all the substituted
amino acids, reproduces the anion dependence of MTX influx observed
with lysine clarifies the basis for this phenomenon (Zhao et al.,
1998b
). Induction of anion-dependent transport in the E45K mutant was
associated with a decrease in influx Vmax,
consistent with the loss of carrier mobility in the absence of
chloride. The data here indicate that it is the introduction of the
positive charge at amino acid 45, and not the loss of the negative
charge at this site, that results in the loss of function. Therefore, the impact of chloride is likely due to neutralization of the positive
charge associated with the lysine or arginine substitution.
The very marked decrease in influx of MTX and the other folates
associated with the aspartate substitution was of particular interest
because this amino acid is of the same charge as, and is close in size
to, glutamate. This resulted in a fall in affinity for all the folates.
The loss of a methylene group in the side chain by this substitution
relocates the carboxyl group by about 1.5 Å, a small change that is
apparently sufficient to alter the interaction among this residue, its
neighboring amino acids, and folates. The impact of the aspartate for
glutamate substitution on carrier transport function has been well
documented in other systems. For instance, the same substitution at
amino acid 121 in the fourth transmembrane domain of the myo-inositol/H
symporter nearly abolished transport activity (Seyfang et al., 1997
).
When this mutation was present in the glutamate transporter at residue 404, potassium-coupled transport was abolished, and glutamate exchange
became obligatory for carrier function (Kavanaugh et al., 1997
).
| |
Footnotes |
|---|
Received July 14, 1999; Accepted October 21, 1999
1 This work was supported by Grant CA-39807 from the National Cancer Institute.
Send reprint requests to: Dr. I. David Goldman, Albert Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, Chanin Two, 1300 Morris Park Ave., Bronx, NY 10461. E-mail: igoldman{at}aecom.yu.edu
| |
Abbreviations |
|---|
RFC1, reduced folate carrier; MTX, methotrexate; 5-CHO-THF, 5-formyltetrahydrofolate; 5-CH3-THF, 5-methyltetrahydrofolate; HBS, HEPES-buffered saline.
| |
References |
|---|
|
|
|---|
defective Chinese hamster ovary cells.
J Biol Chem
270:
17468-17475This article has been cited by other articles:
![]() |
R. Zhao, S. H. Min, A. Qiu, A. Sakaris, G. L. Goldberg, C. Sandoval, J. J. Malatack, D. S. Rosenblatt, and I. D. Goldman The spectrum of mutations in the PCFT gene, coding for an intestinal folate transporter, that are the basis for hereditary folate malabsorption Blood, August 15, 2007; 110(4): 1147 - 1152. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Kneuer, K. U. Honscha, and W. Honscha Sodium-dependent methotrexate carrier-1 is expressed in rat kidney: cloning and functional characterization Am J Physiol Renal Physiol, March 1, 2004; 286(3): F564 - F571. [Abstract] [Full Text] |
||||
![]() |
H. Sadlish, F. M. R. Williams, and W. F. Flintoff Functional Role of Arginine 373 in Substrate Translocation by the Reduced Folate Carrier J. Biol. Chem., October 25, 2002; 277(44): 42105 - 42112. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||